In contrast, even though downregulation of CR2, PIM2, CXCL13 and HLA-DPB1 were demonstrated in all DLBCL and in EBV-negative DLBCL cases, 10 new genes were differentially downregulated. The gene discussed is CR2; the disease is diffuse large B-cell lymphoma.